High-tech metrics are not needed to evaluate the long-term risk that asymptomatic patients with primary angle-closure suspect (PACS) will proceed to glaucoma, data from a Chinese randomized trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback